Phaos Technology Holdings (Caym
$1.95
▼
-0.49%
2026-04-21 08:54:01
phaostech.com
ASE: POAS
Explore Phaos Technology Holdings (Caym stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
—
Current Price
$1.95
52W High / Low
$7.39 / $0.53
Stock P/E
—
Book Value
$-0.06
Dividend Yield
—
ROCE
214.51%
ROE
-10.73%
Face Value
—
EPS
$-0.3
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
25
Beta
—
Debt / Equity
-0.14
Current Ratio
0.4
Quick Ratio
0.32
Forward P/E
—
Price / Sales
155.29
Enterprise Value
$51.96 M
EV / EBITDA
-13.43
EV / Revenue
309.86
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Insulet Corporation | $193.4 | 55.6 | $13.48 B | — | 18.87% | 18.12% | $354.88 / $194.61 | $21.53 |
| 2. | Perspective Therapeutics, Inc. | $4.55 | — | $478.52 M | — | -47.66% | -41.65% | $6.16 / $1.75 | $2.79 |
| 3. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 4. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
| 5. | Lucid Diagnostics Inc. | $1.3 | — | $221.18 M | — | -418.44% | -7.11% | $1.7 / $0.95 | $-0.33 |
| 6. | RxSight, Inc. | $7.44 | — | $314.04 M | — | -16.88% | -13.98% | $16.74 / $5.9 | $6.68 |
| 7. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 0.17 M | 1.88 M | 0.65 M |
| Operating Profit | -3.99 M | -2.39 M | -1.68 M |
| Net Profit | -5.14 M | -2.36 M | -1.67 M |
| EPS in Rs | -0.37 | -0.17 | -0.12 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 1.93 M | 5.18 M | 1.38 M |
| Total Liabilities | 3.9 M | 2.26 M | 4.4 M |
| Equity | -1.96 M | 2.92 M | -3.02 M |
| Current Assets | 1.52 M | 4.73 M | 0.91 M |
| Current Liabilities | 3.8 M | 2.05 M | 3.75 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | -3.65 M | -1.61 M | -1.79 M |
| Investing CF | -0.33 M | -1.65 M | -0.19 M |
| Financing CF | 1.8 M | 5.52 M | 1.91 M |
| Free CF | -3.89 M | -1.73 M | -2.01 M |
| Capex | -0.24 M | -0.12 M | -0.22 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | -91.09% | 189.31% | — |
| Earnings Growth % | -117.69% | -41.49% | — |
| Profit Margin % | -3063.12% | -125.34% | -256.27% |
| Operating Margin % | -2381.32% | -126.76% | -258.2% |
| Gross Margin % | 22.1% | 43.08% | 17.61% |
| EBITDA Margin % | -2946.59% | -113.64% | -222.36% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.